{"nctId":"NCT00837512","briefTitle":"Insulin Delivery Using Microneedles in Type 1 Diabetes","startDateStruct":{"date":"2008-09"},"conditions":["Type 1 Diabetes Mellitus"],"count":16,"armGroups":[{"label":"Microneedle","type":"EXPERIMENTAL","interventionNames":["Device: Microneedle"]},{"label":"Subcutaneous insulin catheter","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Subcutaneous insulin catheter"]}],"interventions":[{"name":"Microneedle","otherNames":[]},{"name":"Subcutaneous insulin catheter","otherNames":["subcutaneous insulin infusion catheter"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* ≥ 8 years of age\n* \\<19 years of age\n* Type 1 Diabetes for at least 2 years\n* Uses a conventional, FDA-approved insulin pump for the past year\n* Uses Lispro insulin\n* Mean hemoglobin A1C ≤ 8.5 % for the past year\n* Body mass index ≤ 85th percentile for age\n* Understand and be willing to adhere to the study protocol\n\nExclusion Criteria:\n\n* Type 2 Diabetes\n* Acanthosis nigricans\n* Clinically significant major organ system disease\n* On glucocorticoid therapy\n* Insulin requirement ≥ 150 U/day\n* Illness on the day of the study\n* Cognitive impairment (IQ \\< 85 or \\> 2 grades behind age-appropriate grade)\n* Pregnant or breast-feeding (if female).","healthyVolunteers":false,"sex":"ALL","minimumAge":"8 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Onset Time (Tmax)","description":"Average time to peak insulin concentration","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":"2"},{"groupId":"OG001","value":"52","spread":"4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":[]}}}